Header Logo

Connection

RAJKUMAR VENKATRAMANI to Child, Preschool

Back to Details
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Child, Preschool.
RAJKUMAR VENKATRAMANI
Connection Strength
2.248
Child, Preschool
  1. Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials. Cancer. 2025 Jun 15; 131(12):e35929.
    View in: PubMed
    Score: 0.077
  2. Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2025 Jun; 72(6):e31673.
    View in: PubMed
    Score: 0.075
  3. Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation. Pediatr Blood Cancer. 2025 Apr; 72(4):e31545.
    View in: PubMed
    Score: 0.075
  4. Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial. Pediatr Blood Cancer. 2025 Feb; 72(2):e31436.
    View in: PubMed
    Score: 0.074
  5. Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatr Blood Cancer. 2024 Oct; 71(10):e31200.
    View in: PubMed
    Score: 0.072
  6. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group. Lancet Oncol. 2024 Jul; 25(7):912-921.
    View in: PubMed
    Score: 0.072
  7. Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report From the Children's Oncology Group ARST0332 Study. J Clin Oncol. 2021 12 10; 39(35):3927-3937.
    View in: PubMed
    Score: 0.059
  8. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021 08; 45(4):100768.
    View in: PubMed
    Score: 0.058
  9. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e195-e197.
    View in: PubMed
    Score: 0.057
  10. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 04; 68(4):e28914.
    View in: PubMed
    Score: 0.057
  11. Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.
    View in: PubMed
    Score: 0.056
  12. Systemic bevacizumab for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2020 Nov; 138:110352.
    View in: PubMed
    Score: 0.055
  13. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 01; 182(1):224-228.
    View in: PubMed
    Score: 0.052
  14. Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013. Pediatr Blood Cancer. 2019 06; 66(6):e27648.
    View in: PubMed
    Score: 0.049
  15. A Multicenter Retrospective Review of Pediatric Leydig Cell Tumor of the Testis. J Pediatr Hematol Oncol. 2019 01; 41(1):74-76.
    View in: PubMed
    Score: 0.049
  16. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid. 2018 11; 28(11):1450-1454.
    View in: PubMed
    Score: 0.048
  17. Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma. Pediatr Blood Cancer. 2019 01; 66(1):e27469.
    View in: PubMed
    Score: 0.048
  18. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 10; 65(10):e27291.
    View in: PubMed
    Score: 0.047
  19. Alveolar soft part sarcoma in children and young adults: A report of 69 cases. Pediatr Blood Cancer. 2018 05; 65(5):e26953.
    View in: PubMed
    Score: 0.046
  20. Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials. Pediatr Blood Cancer. 2017 Jul; 64(7).
    View in: PubMed
    Score: 0.043
  21. Juvenile Granulosa Cell Tumor of the Ovary: A Clinicopathologic Study. J Pediatr Adolesc Gynecol. 2017 Feb; 30(1):138-143.
    View in: PubMed
    Score: 0.042
  22. Multimodality Treatment of Pediatric Esthesioneuroblastoma. Pediatr Blood Cancer. 2016 Mar; 63(3):465-70.
    View in: PubMed
    Score: 0.039
  23. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60.
    View in: PubMed
    Score: 0.039
  24. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis. Am J Clin Oncol. 2014 Dec; 37(6):592-6.
    View in: PubMed
    Score: 0.037
  25. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015 Jan; 102(1):108-13.
    View in: PubMed
    Score: 0.037
  26. Images in clinical medicine. Langerhans'-cell histiocytosis. N Engl J Med. 2014 Sep 11; 371(11):1050.
    View in: PubMed
    Score: 0.036
  27. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatr Blood Cancer. 2014 Sep; 61(9):1679-84.
    View in: PubMed
    Score: 0.035
  28. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014 Aug; 61(8):1357-61.
    View in: PubMed
    Score: 0.035
  29. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. Pediatr Pulmonol. 2015 Jun; 50(6):596-603.
    View in: PubMed
    Score: 0.035
  30. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014 Jul; 61(7):1277-81.
    View in: PubMed
    Score: 0.035
  31. Inflammatory myofibroblastic tumors in childhood. Pediatr Hematol Oncol. 2013 Oct; 30(7):640-5.
    View in: PubMed
    Score: 0.034
  32. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416.
    View in: PubMed
    Score: 0.034
  33. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):942-8.
    View in: PubMed
    Score: 0.033
  34. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. J Neurooncol. 2013 Jun; 113(2):285-91.
    View in: PubMed
    Score: 0.033
  35. A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul; 60(7):1103-7.
    View in: PubMed
    Score: 0.032
  36. Pleuropulmonary blastoma: a single-institution experience. J Pediatr Hematol Oncol. 2012 Jul; 34(5):e182-5.
    View in: PubMed
    Score: 0.031
  37. An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012 Dec 15; 59(7):1324-6.
    View in: PubMed
    Score: 0.031
  38. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):493-8.
    View in: PubMed
    Score: 0.030
  39. Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr Blood Cancer. 2012 Mar; 58(3):380-3.
    View in: PubMed
    Score: 0.028
  40. Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis. Eur J Cancer. 2025 Oct 16; 229:115793.
    View in: PubMed
    Score: 0.020
  41. The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma data. Cancer. 2025 Jul 15; 131(14):e35974.
    View in: PubMed
    Score: 0.019
  42. The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group. HGG Adv. 2025 Jul 10; 6(3):100466.
    View in: PubMed
    Score: 0.019
  43. Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2025 Sep 01; 123(1):54-62.
    View in: PubMed
    Score: 0.019
  44. Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
    View in: PubMed
    Score: 0.019
  45. Late Events Occurring After 5?Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2025 Jan; 72(1):e31421.
    View in: PubMed
    Score: 0.018
  46. Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting. Pediatr Blood Cancer. 2025 01; 72(1):e31347.
    View in: PubMed
    Score: 0.018
  47. Whole Lung Irradiation in Rhabdomyosarcoma With Lung Metastases: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol. 2024 Dec 20; 42(36):4263-4270.
    View in: PubMed
    Score: 0.018
  48. Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2024 Nov; 71(11):e31303.
    View in: PubMed
    Score: 0.018
  49. The impact of margins and re-resection in pediatric synovial sarcoma. Cancer Med. 2024 Sep; 13(17):e70207.
    View in: PubMed
    Score: 0.018
  50. Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2024 Jul; 71(7):e31009.
    View in: PubMed
    Score: 0.018
  51. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group. Cancer. 2024 Jul 15; 130(14):2493-2502.
    View in: PubMed
    Score: 0.018
  52. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group. Cancer. 2023 06 01; 129(11):1735-1743.
    View in: PubMed
    Score: 0.016
  53. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. Lancet Oncol. 2021 09; 22(9):1312-1321.
    View in: PubMed
    Score: 0.015
  54. Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer Med. 2021 02; 10(3):857-866.
    View in: PubMed
    Score: 0.014
  55. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Pediatr Blood Cancer. 2021 03; 68(3):e28832.
    View in: PubMed
    Score: 0.014
  56. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2021 03 15; 127(6):946-956.
    View in: PubMed
    Score: 0.014
  57. Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2021 01 15; 127(2):275-283.
    View in: PubMed
    Score: 0.014
  58. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 01; 68(1):e28741.
    View in: PubMed
    Score: 0.014
  59. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
    View in: PubMed
    Score: 0.014
  60. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e12-e18.
    View in: PubMed
    Score: 0.011
  61. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.011
  62. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution. Histopathology. 2017 Nov; 71(5):813-822.
    View in: PubMed
    Score: 0.011
  63. Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. Pediatr Blood Cancer. 2017 Oct; 64(10).
    View in: PubMed
    Score: 0.011
  64. Myofibroma in Infancy and Childhood. J Pediatr Hematol Oncol. 2017 04; 39(3):e136-e139.
    View in: PubMed
    Score: 0.011
  65. The diagnostic and prognostic value of SALL4 in hepatoblastoma. Histopathology. 2016 Nov; 69(5):822-830.
    View in: PubMed
    Score: 0.010
  66. Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e399-401.
    View in: PubMed
    Score: 0.010
  67. Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.